87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

by Korea University College of MedicineEvolutionary changes in MASLD are associated with differential risks of hepatocellular carcinoma. Credit: Korea University MedicineResearch has revealed that in

Patients with MAFLD have 4.7 times higher risk of developing liver cancer, study finds

by Korea University College of MedicineEvolutionary changes in MASLD are associated with differential risks of hepatocellular carcinoma. Credit: Korea University MedicineResearch has revealed that in
Microscopic cell changes linked to cancer's rapid growth in stiff tissues

Microscopic cell changes linked to cancer's rapid growth in stiff tissues

by Bailey Noah,Texas A&M UniversityResearchers in the Lele Lab analyzing cell imaging data. Credit: Texas A&M EngineeringIn 2022 alone, over 20 million people were diagnosed with cancer,

Microscopic cell changes linked to cancer's rapid growth in stiff tissues

by Bailey Noah,Texas A&M UniversityResearchers in the Lele Lab analyzing cell imaging data. Credit: Texas A&M EngineeringIn 2022 alone, over 20 million people were diagnosed with cancer,
Researchers explore e-bikes for cancer recovery

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:

Researchers explore e-bikes for cancer recovery

by Patty Wellborn,University of British ColumbiaOutline of the CRANK intervention development. APEASE: Acceptability, Practicability, Effectiveness, Affordability, Side-Effects, and Equity; BCT:
Molecular 'ZIP code' draws killer T cells to brain tumors

Molecular 'ZIP code' draws killer T cells to brain tumors

by Levi Gadye,University of California, San FranciscoProgramming tissue-sensing T cells to deliver therapeutics to the brain. Credit:Science(2024). DOI: 10.1126/science.adl4237UCSF s

Molecular 'ZIP code' draws killer T cells to brain tumors

by Levi Gadye,University of California, San FranciscoProgramming tissue-sensing T cells to deliver therapeutics to the brain. Credit:Science(2024). DOI: 10.1126/science.adl4237UCSF s
Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo

Prior authorization delays lead to serious harm for people with cancer, nationwide survey finds

byAmerican Society for Radiation OncologyCredit: American Society for Radiation OncologyA new nationwide survey of more than 750 radiation oncologists confirms that prior authorization harms peo
Even low levels of arsenic in drinking water raise kidney cancer risk, new study finds

Even low levels of arsenic in drinking water raise kidney cancer risk, new study finds

by Ann Kellett,Texas A&M UniversityCredit: Unsplash/CC0 Public DomainNew research findings from the Texas A&M University School of Public Health indicate that exposure to even low levels

Even low levels of arsenic in drinking water raise kidney cancer risk, new study finds

by Ann Kellett,Texas A&M UniversityCredit: Unsplash/CC0 Public DomainNew research findings from the Texas A&M University School of Public Health indicate that exposure to even low levels
Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

by Julia Evangelou Strait,Washington University School of MedicineCredit: CC0 Public DomainAdding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening si

Clinical trial tests new drug to reduce side effect of 'half-matched' stem cell transplants

by Julia Evangelou Strait,Washington University School of MedicineCredit: CC0 Public DomainAdding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening si